However, undetectably low plasma ADAMTS13 activity in the pre-treatment sample, associated with inhibitory ADAMTS13 antibodies, subsequently changed the diagnosis to acquired TTP. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.